Banks
-
US medical technology company Stryker is still looking to bring its debut euro transaction following its recent roadshow, but is waiting for market conditions to improve before pushing its triple-tranche offering into the market.
-
Crédit Agricole is the latest bank to speak to investors about issuing a green bond, at a time when other European names have been marketing deals in the format.
-
Sands China has closed a $2bn five year borrowing with participation from around 10 banks.
-
Babytree Group has bagged HK$1.7bn from its IPO after pricing it at the bottom of guidance amid volatility in equity markets.
-
Online travel agent Tongcheng-Elong Holdings has raised HK$1.41bn ($180m) from its Hong Kong IPO. The leads on the deal had to spend time convincing a number of anchor investors to stay in the transaction given the state of the market.
-
BMW Automotive Finance will open books for its second auto loan ABS of the year on November 27, another three-trancher worth Rmb4.5bn ($648m).
-
No bond issuer is safe in this volatile market. Industrial and Commercial Bank of China (ICBC) learned that the hard way when it was forced to pull a dual-tranche floating rate deal last week. Its failure should serve as a warning sign to other borrowers.
-
Malaysian bank CIMB Group has announced a series of changes to its executive team, effective January 1.
-
Atlantica Yield, the UK-based energy yieldco that was formerly Abengoa Yield, abandoned a $300m eight year high yield bond issue on Tuesday, as yields in the market reached their highest for over two years.
-
Société Générale followed BPCE into the covered bond market on Tuesday, also taking the opportunity to pre-fund ahead of what many market participants expect to be a busy start to 2019.
-
The Federal State of Brandenburg was oversubscribed for its second ever euro benchmark in the 20 year part of the curve on Tuesday. The deal offered a 2bp concession, according to the leads.
-
Boston Scientific, the US medical devices manufacturer, has agreed to buy the UK’s BTG for £3.3bn, with Barclays providing a bridge loan to finance the medical industry transaction and continue the trend of borrowers turning to small banking groups to fund purchases.